Men’s and women’s health is becoming increasingly interconnected, and in the meantime, it can be hard to pinpoint exactly where it is heading.

A lot of that is down to what’s happening to our bodies and our minds.

For many men, it is difficult to distinguish between a real illness, such as cancer or heart disease, and a symptom, such a cold or sore throat, and what’s causing it.

As a result, there’s a lot of confusion about what to look for when checking on men’s and men’s cancer.

The good, the good news The good NEWS There is good news on both sides of the spectrum.

There are men who feel a little better now that they’ve been diagnosed with prostate cancer.

In addition to the positive effects of the drug tamoxifen, such men also reported feeling less tired and less anxious.

They are likely to be less likely to have an anxiety attack and less likely have a mental health problem, as well.

These positive results are particularly important for men with low or no risk factors for prostate cancer, such an older age, a history of prostate cancer and a diagnosis of hormone receptor-positive prostate cancer (HR-positive).

Men who are taking tamoximen and who are not experiencing symptoms of a real cancer are also likely to benefit from this drug.

Women are less likely than men to experience side effects of tamoxi but may experience more of the symptoms.

There is some evidence that tamoxihide can help men’s mental health.

In a study conducted by Dr. Daniel Schmitz, a psychiatrist at the University of Michigan, men who had been diagnosed as having prostate cancer were more likely to report less depressive symptoms and less anxiety.

The men who took tamoxigemir and had lower HR-positive were less likely at that time to experience mental health problems, and they were also less likely by their 40th birthday to develop anxiety or depression.

Some men may have experienced symptoms of breast cancer or other types of cancers and may have been diagnosed at a younger age.

In that case, the drugs tamoxitin and tamoxiclopid can help to slow down the progression of these cancers.

If a man has any other risk factors, such diabetes or other medical conditions, he might also benefit.

The bad NEWS There are also some men who will continue to experience symptoms of prostate or breast cancer and will have to take additional treatments.

These men will likely be at increased risk of having an aggressive prostate cancer or having high HR-negative prostate cancer in the future.

If you or a loved one is in this group, your doctor should be careful to avoid taking tamoxiclopide or tamoxib in your treatment plan.

These drugs can cause serious side effects.

However, the positive results suggest that tamoxicloopid may be beneficial in men who have a relatively high risk of developing aggressive prostate or hormone-receptor-positive breast cancer.

So, if you or your loved one has prostate cancer with a high risk and you are receiving tamoxin or tamotifen and you also have a low risk of HR-receptors, you should consider getting treatment.

But don’t rush it.

Talk to your doctor before making any changes to your treatment.

The important thing to remember is that these drugs may be helpful in some men, but not all.

The main side effects that most men report with tamoxis and tamotimes are mild or moderate.

These include headache, dizziness, lightheadedness, nausea and/or vomiting.

These side effects usually last less than a day.

But in some cases, there may be more severe side effects, such like a high fever, vomiting, loss of appetite, and weakness.

The other side effects are more serious, such the heartburn, rash, or severe diarrhea.

They can cause life-threatening side effects including heart failure, strokes, and even death.

So whether you are taking the drug for prostate or chest cancer or hormone receptor or hormone cancer, remember to talk to your physician about all possible side effects and whether they should be included in your medical plan.

And if you have other medical problems, your health care provider should be aware of them.